About CJC-1295 no DAC
Related-formulation evidence · Identity confirmation needed
What it is studied for
Listed as a GHRH-related laboratory material without a drug-affinity complex (DAC), for study of pituitary growth-hormone signaling. Confirm its exact sequence and identity against the lot documentation.
What selected research found
Teichman et al. (2006) reported increased GH and IGF-I in healthy adults using long-acting CJC-1295.
Evidence limits
Do not assume that the long-acting clinical trial applies to material sold as “no DAC.” The study does not establish this listing’s duration of action, efficacy or safety.
Selected sources
References reviewed October 10, 2026.
Research use only. These notes summarize selected publications; they are not a systematic review, medical advice, dosing instructions, or evidence about this product lot. Clinical studies used controlled study formulations and supervision. AuraBio materials are not for human or veterinary use. Review the exact material identity and available lot documentation for your laboratory application.






Reviews
There are no reviews yet.